Literature DB >> 22281202

Proton magnetic resonance spectroscopy in pediatric obsessive-compulsive disorder: longitudinal study before and after treatment.

Luisa Lázaro1, Núria Bargalló, Susana Andrés, Carles Falcón, Astrid Morer, Carme Junqué, Josefina Castro-Fornieles.   

Abstract

Abnormalities in neurochemical compounds in obsessive-compulsive disorder (OCD) may help increase our knowledge of neurobiological abnormalities in the fronto-subcortical circuits. The aims of this exploratory study were to identify with in vivo magnetic resonance spectroscopy ((1)H-MRS) the possible alterations in neurometabolites in a group of drug naïve children and adolescents with OCD in comparison with a control group and to determine whether there was any effect of treatment on the metabolite levels. Eleven OCD children and adolescents (age range 9-17 years; 6 male, 5 female) and twelve healthy subjects with similar age, sex and estimated intellectual quotient were studied. Proton magnetic resonance spectroscopy at 1.5 T was used. We placed 3 voxels, one bilaterally located involving anterior cingulate-medial frontal regions, and one in each striatal region involving the caudate and putaminal regions. Concentrations of creatine (Cr), myo-inositol (mI), total Cho (glycerophosphocholine+phosphocholine), total NAA (N-acetyl aspartate+N-acetyl aspartylglutamate), and total Glx (glutamate+glutamine) were calculated. We found significantly lower concentrations of total Cho in left striatum in OCD patients compared with healthy subjects. The difference in Cho concentrations in left striatum between the two groups did not change over time and persisted at follow-up assessment. Like the control subjects, OCD patients undergoing pharmacological treatment and clinical recovery showed no significant changes in neurometabolic activity between the first and second evaluations. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281202     DOI: 10.1016/j.pscychresns.2011.01.017

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.

Authors:  Joseph O'Neill; John Piacentini; Susanna Chang; Ronald Ly; Tsz M Lai; Casey C Armstrong; Lindsey Bergman; Michelle Rozenman; Tara Peris; Allison Vreeland; Ross Mudgway; Jennifer G Levitt; Noriko Salamon; Stefan Posse; Gerhard S Hellemann; Jeffry R Alger; James T McCracken; Erika L Nurmi
Journal:  Neuropsychopharmacology       Date:  2017-04-04       Impact factor: 7.853

2.  An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.

Authors:  Brian P Brennan; Olga Tkachenko; Zachary J Schwab; Richard J Juelich; Erin M Ryan; Alison J Athey; Harrison G Pope; Michael A Jenike; Justin T Baker; William D S Killgore; James I Hudson; J Eric Jensen; Scott L Rauch
Journal:  Neuropsychopharmacology       Date:  2015-02-09       Impact factor: 7.853

3.  1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.

Authors:  Raşit Tükel; Kubilay Aydın; Erhan Ertekin; Seda Şahin Özyıldırım; Mehmet Barburoğlu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-26       Impact factor: 5.270

Review 4.  The underlying neurobiology of key functional domains in young people with mood and anxiety disorders: a systematic review.

Authors:  Frank Iorfino; Ian B Hickie; Rico S C Lee; Jim Lagopoulos; Daniel F Hermens
Journal:  BMC Psychiatry       Date:  2016-05-23       Impact factor: 3.630

5.  Neurochemicals measured by (1)H-MR spectroscopy: putative vulnerability biomarkers for obsessive compulsive disorder.

Authors:  Sundar Gnanavel; Pratap Sharan; Sudhir Khandelwal; Uma Sharma; Naranamangalam R Jagannathan
Journal:  MAGMA       Date:  2013-12-12       Impact factor: 2.310

6.  Insular cortex metabolite changes in obstructive sleep apnea.

Authors:  Santosh K Yadav; Rajesh Kumar; Paul M Macey; Mary A Woo; Frisca L Yan-Go; Ronald M Harper
Journal:  Sleep       Date:  2014-05-01       Impact factor: 5.849

7.  Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.

Authors:  Helen Blair Simpson; Lawrence S Kegeles; Liane Hunter; Xiangling Mao; Page Van Meter; Xiaoyan Xu; Marcia B Kimeldorf; Sarah L Pearlstein; Mark Slifstein; Dikoma C Shungu
Journal:  Psychiatry Res       Date:  2015-02-03       Impact factor: 3.222

8.  Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder.

Authors:  Marjan Biria; Lucia-Manuela Cantonas; Paula Banca
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 9.  A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder.

Authors:  Brian P Brennan; Scott L Rauch; J Eric Jensen; Harrison G Pope
Journal:  Biol Psychiatry       Date:  2012-07-24       Impact factor: 13.382

10.  Cingulate and thalamic metabolites in obsessive-compulsive disorder.

Authors:  Joseph O'Neill; Tsz M Lai; Courtney Sheen; Giulia C Salgari; Ronald Ly; Casey Armstrong; Susanna Chang; Jennifer G Levitt; Noriko Salamon; Jeffry R Alger; Jamie D Feusner
Journal:  Psychiatry Res Neuroimaging       Date:  2016-05-24       Impact factor: 2.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.